Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis
Diamantis I. Tsilimigras, Demetrios Moris, Rittal Mehta, et al.
HPB (2020) Vol. 22, Iss. 12, pp. 1667-1674
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Cholangiocarcinoma — novel biological insights and therapeutic strategies
Sumera I. Ilyas, Silvia Affò, Lipika Goyal, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 470-486
Open Access | Times Cited: 93
“Biological R2” Resection for Intrahepatic Cholangiocarcinoma: Identification of Patients at Risk for Poor Oncologic Outcomes after Curative-Intent Resection
Jun Kawashima, Yutaka Endo, Selamawit Woldesenbet, et al.
HPB (2025)
Closed Access | Times Cited: 2
Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing–Assisted Multiomics Analysis
Xuanwen Bao, Qiong Li, Jinzhang Chen, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 7, pp. 811-828
Open Access | Times Cited: 51
Development and validation of a new prognostic immune–inflammatory–nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study
Jiang Zhu, Denghui Wang, Chang Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma
Jun Kawashima, Kota Sahara, Feng Shen, et al.
Journal of Gastrointestinal Surgery (2024) Vol. 28, Iss. 1, pp. 18-25
Closed Access | Times Cited: 9
GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity
Luis I. Ruffolo, Katherine M. Jackson, Peyton C. Kuhlers, et al.
Gut (2021) Vol. 71, Iss. 7, pp. 1386-1398
Open Access | Times Cited: 51
Recurrent Intrahepatic Cholangiocarcinoma: A 10-Point Score to Predict Post-Recurrence Survival and Guide Treatment of Recurrence
Diamantis I. Tsilimigras, Yutaka Endo, Alfredo Guglielmi, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 7, pp. 4427-4435
Closed Access | Times Cited: 8
The Value of Platelet-to-Lymphocyte Ratio as a Prognostic Marker in Cholangiocarcinoma: A Systematic Review and Meta-Analysis
Dong Liu, Zoltán Czigány, Lara R. Heij, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 438-438
Open Access | Times Cited: 28
Albumin-Bilirubin Grade and Tumor Burden Score Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma After Hepatic Resection: a Multi-Institutional Analysis
Muhammad Musaab Munir, Yutaka Endo, Henrique A. Lima, et al.
Journal of Gastrointestinal Surgery (2023) Vol. 27, Iss. 3, pp. 544-554
Closed Access | Times Cited: 15
Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?
Diamantis I. Tsilimigras, J. Madison Hyer, Anghela Z. Paredes, et al.
Annals of Surgical Oncology (2020) Vol. 28, Iss. 4, pp. 1970-1978
Closed Access | Times Cited: 38
Prognostic and Clinicopathological Significance of the Systemic Immune-Inflammation Index in Patients With Renal Cell Carcinoma: A Meta-Analysis
Mingyu Jin, Shaoying Yuan, Yiming Yuan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 32
Early Onset Intrahepatic Cholangiocarcinoma: Clinical Characteristics, Oncological Outcomes, and Genomic/Transcriptomic Features
Diamantis I. Tsilimigras, Xu Han, Alfredo Guglielmi, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 5, pp. 3087-3097
Open Access | Times Cited: 4
Construction and validation of a novel tumor morphology immune inflammatory nutritional score (TIIN score) for intrahepatic cholangiocarcinoma: a multicenter study
Haofeng Zhang, Guan Huang, Qingshan Li, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Predictive Value of the Systemic Immune-Inflammation Index for Intravenous Immunoglobulin Resistance and Cardiovascular Complications in Kawasaki Disease
Xiaoliang Liu, Shuran Shao, Lin Wang, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 27
Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal Cholangiocarcinoma
Kota Sahara, Diamantis I. Tsilimigras, Junya Toyoda, et al.
Annals of Surgical Oncology (2021) Vol. 28, Iss. 8, pp. 4205-4213
Closed Access | Times Cited: 24
The prognostic value of neutrophil-to-lymphocyte ratio in cholangiocarcinoma: a systematic review and meta-analysis
Dong Liu, Lara R. Heij, Zoltán Czigány, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Prognostic and Clinical Value of the Systemic Immune-Inflammation Index in Biliary Tract Cancer: A Meta-Analysis
Xiulan Peng, Xia Wang, Hua Li, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 17
Preoperative prediction of lymph node metastasis in intrahepatic cholangiocarcinoma: an integrative approach combining ultrasound-based radiomics and inflammation-related markers
Yuting Peng, Jin-shu Pang, Peng Lin, et al.
BMC Medical Imaging (2025) Vol. 25, Iss. 1
Open Access
Nomogram-derived immune-inflammation-nutrition score could act as a novel prognostic indicator for patients with head and neck squamous cell carcinoma
Wenyan Wang, Yue Chen, Qian Chen, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Role of genomics in liver transplantation for cholangiocarcinoma
Nadine Soliman, Anaum Maqsood, Ashton A. Connor
Current Opinion in Organ Transplantation (2025)
Closed Access
Model of End-Stage Liver Disease–alpha-fetoprotein–tumor burden (MELD-AFP-TBS) score to stratify prognosis after liver resection for hepatocellular carcinoma
Jun Kawashima, Miho Akabane, Mujtaba Khalil, et al.
Surgery (2025) Vol. 183, pp. 109388-109388
Closed Access
Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection
Zeyu Zhang, Yufan Zhou, Kuan Hu, et al.
World Journal of Surgical Oncology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 26
A Novel Classification of Intrahepatic Cholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional Analysis
Diamantis I. Tsilimigras, J. Madison Hyer, Anghela Z. Paredes, et al.
Annals of Surgical Oncology (2020) Vol. 27, Iss. 13, pp. 5224-5232
Closed Access | Times Cited: 24
Role of the Systemic Immune-Inflammation Index in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Ipilimumab plus Nivolumab
Viktoria Stühler, Lisa Herrmann, Steffen Rausch, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2972-2972
Open Access | Times Cited: 16
Interleukin-6 and Lymphocyte-to-Monocyte Ratio Indices Identify Patients with Intrahepatic Cholangiocarcinoma
Teerachat Saeheng, Juntra Karbwang, Kesara Na‐Bangchang
Biomedicines (2024) Vol. 12, Iss. 4, pp. 844-844
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top